This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Günthard, H. F. Articles by Wong, J. K. Search for Related Content PubMed PubMed Citation Articles by Günthard, H. F. Articles by Wong, J. K.

Journal of Virology, November 1999, p. 9404-9412, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy

Huldrych F. Günthard,^1, Simon D. W. Frost,² Andrew J. Leigh-Brown,² Caroline C. Ignacio,¹ Kristin Kee,¹ Alan S. Perelson,³ Celsa A. Spina,^1,4 Diane V. Havlir,¹ Marjan Hezareh,¹ David J. Looney,^1,4 Douglas D. Richman,^1,4 and Joseph K. Wong^1,4,*

University of California, San Diego,¹ and San Diego Veterans Affairs Healthcare System,⁴ San Diego, California; University of Edinburgh, Edinburgh, Scotland²; and the Los Alamos National Laboratory, Los Alamos, New Mexico³

Received 17 March 1999/Accepted 9 July 1999

In human immunodeficiency virus (HIV)-infected patients treated with potent antiretroviral therapy, the persistence of latently infected cells may reflect the long decay half-life of this cellular reservoir or ongoing viral replication at low levels with continuous replenishment of the population or both. To address these possibilities, sequences encompassing the C2 and V3 domains of HIV-1 env were analyzed from virus present in baseline plasma and from viral isolates obtained after 2 years of suppressive therapy in six patients. The presence of sequence changes consistent with evolution was demonstrated for three subjects and correlated with less complete suppression of viral replication, as indicated by the rapidity of the initial virus load decline or the intermittent reappearance of even low levels of detectable viremia. Together, these results provide evidence for ongoing replication. In the remaining three patients, virus recovered after 2 years of therapy was either genotypically contemporary with or ancestral to virus present in plasma 2 years before, indicating that virus recovery had indeed resulted from activation of latently infected cells.

---

^* Corresponding author. Mailing address: Stein Clinical Research Building No. 326, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0679. Phone: (619) 552-8585, ext. 7193. Fax: (619) 552-7445. E-mail: j2wong{at}ucsd.edu.

Present address: University of Zürich, Zürich, Switzerland.

---

Journal of Virology, November 1999, p. 9404-9412, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

This article has been cited by other articles:

• Joos, B., Trkola, A., Kuster, H., Aceto, L., Fischer, M., Stiegler, G., Armbruster, C., Vcelar, B., Katinger, H., Gunthard, H. F. (2006). Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).. Antimicrob. Agents Chemother. 50: 1773-1779 [Abstract] [Full Text]  
• Tobin, N. H., Learn, G. H., Holte, S. E., Wang, Y., Melvin, A. J., McKernan, J. L., Pawluk, D. M., Mohan, K. M., Lewis, P. F., Mullins, J. I., Frenkel, L. M. (2005). Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus. J. Virol. 79: 9625-9634 [Abstract] [Full Text]  
• Joos, B., Trkola, A., Fischer, M., Kuster, H., Rusert, P., Leemann, C., Boni, J., Oxenius, A., Price, D. A., Phillips, R. E., Wong, J. K., Hirschel, B., Weber, R., Gunthard, H. F., the Swiss HIV Cohort Study, (2005). Low Human Immunodeficiency Virus Envelope Diversity Correlates with Low In Vitro Replication Capacity and Predicts Spontaneous Control of Plasma Viremia after Treatment Interruptions. J. Virol. 79: 9026-9037 [Abstract] [Full Text]  
• Monie, D., Simmons, R. P., Nettles, R. E., Kieffer, T. L., Zhou, Y., Zhang, H., Karmon, S., Ingersoll, R., Chadwick, K., Zhang, H., Margolick, J. B., Quinn, T. C., Ray, S. C., Wind-Rotolo, M., Miller, M., Persaud, D., Siliciano, R. F. (2005). A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+ T Cells of Viremic Patients. J. Virol. 79: 5185-5202 [Abstract] [Full Text]  
• Sharkey, M., Triques, K., Kuritzkes, D. R., Stevenson, M. (2005). In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA. J. Virol. 79: 5203-5210 [Abstract] [Full Text]  
• Casazza, J. P., Betts, M. R., Hill, B. J., Brenchley, J. M., Price, D. A., Douek, D. C., Koup, R. A. (2005). Immunologic Pressure within Class I-Restricted Cognate Human Immunodeficiency Virus Epitopes during Highly Active Antiretroviral Therapy. J. Virol. 79: 3653-3663 [Abstract] [Full Text]  
• Nettles, R. E., Kieffer, T. L., Kwon, P., Monie, D., Han, Y., Parsons, T., Cofrancesco, J. Jr, Gallant, J. E., Quinn, T. C., Jackson, B., Flexner, C., Carson, K., Ray, S., Persaud, D., Siliciano, R. F. (2005). Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART. JAMA 293: 817-829 [Abstract] [Full Text]  
• Strain, M. C., Letendre, S., Pillai, S. K., Russell, T., Ignacio, C. C., Gunthard, H. F., Good, B., Smith, D. M., Wolinsky, S. M., Furtado, M., Marquie-Beck, J., Durelle, J., Grant, I., Richman, D. D., Marcotte, T., McCutchan, J. A., Ellis, R. J., Wong, J. K. (2005). Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy. J. Virol. 79: 1772-1788 [Abstract] [Full Text]  
• Di Mascio, M., Markowitz, M., Louie, M., Hurley, A., Hogan, C., Simon, V., Follmann, D., Ho, D. D., Perelson, A. S. (2004). Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Type 1 Infection. J. Virol. 78: 10566-10573 [Abstract] [Full Text]  
• Wightman, F., Walters, T., Ayres, A., Bowden, S., Bartholomeusz, A., Lau, D., Locarnini, S., Lewin, S. R. (2004). Comparison of Sequence Analysis and a Novel Discriminatory Real-Time PCR Assay for Detection and Quantification of Lamivudine-Resistant Hepatitis B Virus Strains. J. Clin. Microbiol. 42: 3809-3812 [Abstract] [Full Text]  
• Scott, P., Arnold, E., Evans, B., Pozniak, A., Moyle, G., Shahmenesh, M., White, D., Shirley, J., Cane, P., Pillay, D. (2004). Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. J Antimicrob Chemother 53: 469-473 [Abstract] [Full Text]  
• Bello, G., Casado, C., Garcia, S., Rodriguez, C., del Romero, J., Lopez-Galindez, C. (2004). Co-existence of recent and ancestral nucleotide sequences in viral quasispecies of human immunodeficiency virus type 1 patients. J. Gen. Virol. 85: 399-407 [Abstract] [Full Text]  
• Persaud, D., Siberry, G. K., Ahonkhai, A., Kajdas, J., Monie, D., Hutton, N., Watson, D. C., Quinn, T. C., Ray, S. C., Siliciano, R. F. (2004). Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads. J. Virol. 78: 968-979 [Abstract] [Full Text]  
• Rodrigo, A. G., Goode, M., Forsberg, R., Ross, H. A., Drummond, A. (2003). Inferring Evolutionary Rates Using Serially Sampled Sequences from Several Populations. Mol Biol Evol 20: 2010-2018 [Abstract] [Full Text]  
• Di Mascio, M., Markowitz, M., Louie, M., Hogan, C., Hurley, A., Chung, C., Ho, D. D., Perelson, A. S. (2003). Viral Blip Dynamics during Highly Active Antiretroviral Therapy. J. Virol. 77: 12165-12172 [Abstract] [Full Text]  
• Havlir, D. V., Strain, M. C., Clerici, M., Ignacio, C., Trabattoni, D., Ferrante, P., Wong, J. K. (2003). Productive Infection Maintains a Dynamic Steady State of Residual Viremia in Human Immunodeficiency Virus Type 1-Infected Persons Treated with Suppressive Antiretroviral Therapy for Five Years. J. Virol. 77: 11212-11219 [Abstract] [Full Text]  
• Frenkel, L. M., Wang, Y., Learn, G. H., McKernan, J. L., Ellis, G. M., Mohan, K. M., Holte, S. E., De Vange, S. M., Pawluk, D. M., Melvin, A. J., Lewis, P. F., Heath, L. M., Beck, I. A., Mahalanabis, M., Naugler, W. E., Tobin, N. H., Mullins, J. I. (2003). Multiple Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy. J. Virol. 77: 5721-5730 [Abstract] [Full Text]  
• Strain, M. C., Gunthard, H. F., Havlir, D. V., Ignacio, C. C., Smith, D. M., Leigh-Brown, A. J., Macaranas, T. R., Lam, R. Y., Daly, O. A., Fischer, M., Opravil, M., Levine, H., Bacheler, L., Spina, C. A., Richman, D. D., Wong, J. K. (2003). Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence. Proc. Natl. Acad. Sci. USA 100: 4819-4824 [Abstract] [Full Text]  
• Persaud, D., Zhou, Y., Siliciano, J. M., Siliciano, R. F. (2003). Latency in Human Immunodeficiency Virus Type 1 Infection: No Easy Answers. J. Virol. 77: 1659-1665 [Full Text]  
• Ruff, C. T., Ray, S. C., Kwon, P., Zinn, R., Pendleton, A., Hutton, N., Ashworth, R., Gange, S., Quinn, T. C., Siliciano, R. F., Persaud, D. (2002). Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure. J. Virol. 76: 9481-9492 [Abstract] [Full Text]  
• van Rij, R. P., Visser, J. A., van Praag, R. M. E., Rientsma, R., Prins, J. M., Lange, J. M. A., Schuitemaker, H. (2002). Both R5 and X4 Human Immunodeficiency Virus Type 1 Variants Persist during Prolonged Therapy with Five Antiretroviral Drugs. J. Virol. 76: 3054-3058 [Abstract] [Full Text]  
• Brooks, D. G., Zack, J. A. (2002). Effect of Latent Human Immunodeficiency Virus Infection on Cell Surface Phenotype. J. Virol. 76: 1673-1681 [Abstract] [Full Text]  
• Zhu, T., Muthui, D., Holte, S., Nickle, D., Feng, F., Brodie, S., Hwangbo, Y., Mullins, J. I., Corey, L. (2002). Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy. J. Virol. 76: 707-716 [Abstract] [Full Text]  
• Ortiz, G. M., Hu, J., Goldwitz, J. A., Chandwani, R., Larsson, M., Bhardwaj, N., Bonhoeffer, S., Ramratnam, B., Zhang, L., Markowitz, M. M., Nixon, D. F. (2002). Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses in Subjects Treated Early after Infection. J. Virol. 76: 411-415 [Abstract] [Full Text]  
• Lawn, S. D., Butera, S. T., Folks, T. M. (2001). Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection. Clin. Microbiol. Rev. 14: 753-777 [Abstract] [Full Text]  
• Havlir, D. V., Bassett, R., Levitan, D., Gilbert, P., Tebas, P., Collier, A. C., Hirsch, M. S., Ignacio, C., Condra, J., Gunthard, H. F., Richman, D. D., Wong, J. K. (2001). Prevalence and Predictive Value of Intermittent Viremia With Combination HIV Therapy. JAMA 286: 171-179 [Abstract] [Full Text]  
• Hermankova, M., Ray, S. C., Ruff, C., Powell-Davis, M., Ingersoll, R., D'Aquila, R. T., Quinn, T. C., Siliciano, J. D., Siliciano, R. F., Persaud, D. (2001). HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy. JAMA 286: 196-207 [Abstract] [Full Text]  
• Deeks, S. G. (2001). Durable HIV Treatment Benefit Despite Low-Level Viremia: Reassessing Definitions of Success or Failure. JAMA 286: 224-226 [Full Text]  
• Martinez-Picado, J., DePasquale, M. P., Kartsonis, N., Hanna, G. J., Wong, J., Finzi, D., Rosenberg, E., Gunthard, H. F., Sutton, L., Savara, A., Petropoulos, C. J., Hellmann, N., Walker, B. D., Richman, D. D., Siliciano, R., D'Aquila, R. T. (2000). Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc. Natl. Acad. Sci. USA 97: 10948-10953 [Abstract] [Full Text]  
• Crowe, S. M., Sonza, S. (2000). HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 68: 345-350 [Abstract] [Full Text]  
• Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., Bhattacharya, T. (2000). Timing the Ancestor of the HIV-1 Pandemic Strains. Science 288: 1789-1796 [Abstract] [Full Text]  
• Kuster, H., Opravil, M., Ott, P., Schlaepfer, E., Fischer, M., Gunthard, H. F., Luthy, R., Weber, R., Cone, R. W. (2000). Treatment-Induced Decline of Human Immunodeficiency Virus-1 p24 and HIV-1 RNA in Lymphoid Tissue of Patients with Early Human Immunodeficiency Virus-1 Infection. Am. J. Pathol. 156: 1973-1986 [Abstract] [Full Text]  
• Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schechter, M., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., Volberding, P. A. (2000). Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society-USA Panel. JAMA 283: 381-390 [Abstract] [Full Text]